PDLIM2 and breast carcinoma: When data for TNBC tumours was separated from other breast cancer subtypes it was observed that PDLIM2 expression was overall higher in the stroma of TNBC (62% compared with 37% stromal expression in non-TNBC tumours (Figure 1C), including higher expression in PDLIM2-negative TNBC tumours (circa 50%), than in the other breast cancer subtypes (circa 30%), (Figure 1C) and (11).